Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

The Challenges of a Complex and Innovative Telehealth Project: A Qualitative Evaluation of the Eastern Quebec Telepathology Network.

Alami H, Fortin JP, Gagnon MP, Pollender H, Têtu B, Tanguay F.

Int J Health Policy Manag. 2017 Sep 13;7(5):421-432. doi: 10.15171/ijhpm.2017.106.

2.

Association between physical activity and the expression of mediators of inflammation in normal breast tissue among premenopausal and postmenopausal women.

Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Diorio C.

Cytokine. 2018 Feb;102:151-160. doi: 10.1016/j.cyto.2017.08.007. Epub 2017 Nov 6.

PMID:
29102166
3.

Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.

Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Sanschagrin F, Bureau A, Poirier B, Diorio C.

PLoS One. 2017 Aug 28;12(8):e0183579. doi: 10.1371/journal.pone.0183579. eCollection 2017.

4.

A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.

Chua MLK, Lo W, Pintilie M, Murgic J, Lalonde E, Bhandari V, Mahamud O, Gopalan A, Kweldam CF, van Leenders GJLH, Verhoef EI, Hoogland AM, Livingstone J, Berlin A, Dal Pra A, Meng A, Zhang J, Orain M, Picard V, Hovington H, Bergeron A, Lacombe L, Fradet Y, Têtu B, Reuter VE, Fleshner N, Fraser M, Boutros PC, van der Kwast TH, Bristow RG.

Eur Urol. 2017 Nov;72(5):665-674. doi: 10.1016/j.eururo.2017.04.034. Epub 2017 May 13.

PMID:
28511883
5.

Genomic hallmarks of localized, non-indolent prostate cancer.

Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X, Masella AP, Fox NS, Xie M, Prokopec SD, Berlin A, Lalonde E, Ahmed M, Trudel D, Luo X, Beck TA, Meng A, Zhang J, D'Costa A, Denroche RE, Kong H, Espiritu SM, Chua ML, Wong A, Chong T, Sam M, Johns J, Timms L, Buchner NB, Orain M, Picard V, Hovington H, Murison A, Kron K, Harding NJ, P'ng C, Houlahan KE, Chu KC, Lo B, Nguyen F, Li CH, Sun RX, de Borja R, Cooper CI, Hopkins JF, Govind SK, Fung C, Waggott D, Green J, Haider S, Chan-Seng-Yue MA, Jung E, Wang Z, Bergeron A, Dal Pra A, Lacombe L, Collins CC, Sahinalp C, Lupien M, Fleshner NE, He HH, Fradet Y, Tetu B, van der Kwast T, McPherson JD, Bristow RG, Boutros PC.

Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9.

PMID:
28068672
6.

Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism.

Audet-Delage Y, Rouleau M, Rouleau M, Roberge J, Miard S, Picard F, Têtu B, Guillemette C.

Mol Pharmacol. 2017 Mar;91(3):167-177. doi: 10.1124/mol.116.106161. Epub 2017 Jan 3.

7.

Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women.

Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Sanschagrin F, Bureau A, Poirier B, Diorio C.

Menopause. 2017 May;24(5):524-535. doi: 10.1097/GME.0000000000000794.

PMID:
28002200
8.

Evaluation of Antioxidant Intakes in Relation to Inflammatory Markers Expression Within the Normal Breast Tissue of Breast Cancer Patients.

Larouche D, Hanna M, Chang SL, Jacob S, Têtu B, Diorio C.

Integr Cancer Ther. 2017 Dec;16(4):485-495. doi: 10.1177/1534735416676584. Epub 2016 Nov 30.

9.

Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.

Lalonde E, Alkallas R, Chua MLK, Fraser M, Haider S, Meng A, Zheng J, Yao CQ, Picard V, Orain M, Hovington H, Murgic J, Berlin A, Lacombe L, Bergeron A, Fradet Y, Têtu B, Lindberg J, Egevad L, Grönberg H, Ross-Adams H, Lamb AD, Halim S, Dunning MJ, Neal DE, Pintilie M, van der Kwast T, Bristow RG, Boutros PC.

Eur Urol. 2017 Jul;72(1):22-31. doi: 10.1016/j.eururo.2016.10.013. Epub 2016 Nov 1.

PMID:
27815082
10.

Association of Telomere Length with Breast Cancer Prognostic Factors.

Ennour-Idrissi K, Têtu B, Maunsell E, Poirier B, Montoni A, Rochette PJ, Diorio C.

PLoS One. 2016 Aug 29;11(8):e0161903. doi: 10.1371/journal.pone.0161903. eCollection 2016.

11.

A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.

Neveu B, Jain P, Têtu B, Wu L, Fradet Y, Pouliot F.

Oncotarget. 2016 Jan 12;7(2):1300-10. doi: 10.18632/oncotarget.6360.

12.

Impacts of a Large Decentralized Telepathology Network in Canada.

Pare G, Meyer J, Trudel MC, Tetu B.

Telemed J E Health. 2016 Mar;22(3):246-50. doi: 10.1089/tmj.2015.0083. Epub 2015 Aug 7.

PMID:
26252758
13.

The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.

Belledant A, Hovington H, Garcia L, Caron P, Brisson H, Villeneuve L, Simonyan D, Têtu B, Fradet Y, Lacombe L, Guillemette C, Lévesque E.

Eur Urol. 2016 Apr;69(4):601-9. doi: 10.1016/j.eururo.2015.06.054. Epub 2015 Jul 26.

PMID:
26215610
14.

Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy.

Desmeules P, Hovington H, Nguilé-Makao M, Léger C, Caron A, Lacombe L, Fradet Y, Têtu B, Fradet V.

Diagn Pathol. 2015 Jun 13;10:67. doi: 10.1186/s13000-015-0294-0.

15.

Spatial genomic heterogeneity within localized, multifocal prostate cancer.

Boutros PC, Fraser M, Harding NJ, de Borja R, Trudel D, Lalonde E, Meng A, Hennings-Yeomans PH, McPherson A, Sabelnykova VY, Zia A, Fox NS, Livingstone J, Shiah YJ, Wang J, Beck TA, Have CL, Chong T, Sam M, Johns J, Timms L, Buchner N, Wong A, Watson JD, Simmons TT, P'ng C, Zafarana G, Nguyen F, Luo X, Chu KC, Prokopec SD, Sykes J, Dal Pra A, Berlin A, Brown A, Chan-Seng-Yue MA, Yousif F, Denroche RE, Chong LC, Chen GM, Jung E, Fung C, Starmans MH, Chen H, Govind SK, Hawley J, D'Costa A, Pintilie M, Waggott D, Hach F, Lambin P, Muthuswamy LB, Cooper C, Eeles R, Neal D, Tetu B, Sahinalp C, Stein LD, Fleshner N, Shah SP, Collins CC, Hudson TJ, McPherson JD, van der Kwast T, Bristow RG.

Nat Genet. 2015 Jul;47(7):736-45. doi: 10.1038/ng.3315. Epub 2015 May 25.

PMID:
26005866
16.

Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.

Desmeules P, Trudel D, Turcotte S, Sirois J, Plante M, Grégoire J, Renaud MC, Orain M, Têtu B, Bairati I.

Hum Pathol. 2015 May;46(5):739-45. doi: 10.1016/j.humpath.2015.01.014. Epub 2015 Feb 12.

PMID:
25771900
17.

Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis.

Paquet ÉR, Hovington H, Brisson H, Lacombe C, Larue H, Têtu B, Lacombe L, Fradet Y, Lebel M.

Biomark Med. 2015;9(3):187-97. doi: 10.2217/bmm.14.115.

PMID:
25731206
18.

Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal women.

Hanna M, Dumas I, Jacob S, Têtu B, Diorio C.

Menopause. 2015 Sep;22(9):964-75. doi: 10.1097/GME.0000000000000433.

PMID:
25710783
19.

The Eastern Québec Telepathology Network: a three-year experience of clinical diagnostic services.

Têtu B, Perron É, Louahlia S, Paré G, Trudel MC, Meyer J.

Diagn Pathol. 2014;9 Suppl 1:S1. doi: 10.1186/1746-1596-9-S1-S1. Epub 2014 Dec 19.

20.

Online teaching of inflammatory skin pathology by a French-speaking International University Network.

Perron E, Battistella M, Vergier B, Fiche M, Bertheau P, Têtu B; working group of the french College of Pathologists (CoPath/CUFP).

Diagn Pathol. 2014;9 Suppl 1:S5. doi: 10.1186/1746-1596-9-S1-S5. Epub 2014 Dec 19.

21.

Telepathology for intraoperative consultations and expert opinions: the experience of the Eastern Québec Telepathology Network.

Perron E, Louahlia S, Nadeau L, Boilard F, Ing M, Orain M, Têtu B.

Arch Pathol Lab Med. 2014 Sep;138(9):1223-8. doi: 10.5858/arpa.2013-0466-OA.

PMID:
25171705
22.

[The Canadian Association of Pathology guidelines for establishing a diagnostic telepathology service using whole-slide imaging].

Têtu B.

Ann Pathol. 2014 Aug;34(4):256-7. doi: 10.1016/j.annpat.2014.06.012. Epub 2014 Jul 22. French. No abstract available.

PMID:
25132434
23.

Guidelines from the Canadian Association of Pathologists for establishing a telepathology service for anatomic pathology using whole-slide imaging.

Canadian Association of Pathologists Telepathology Guidelines Committee, Bernard C, Chandrakanth SA, Cornell IS, Dalton J, Evans A, Garcia BM, Godin C, Godlewski M, Jansen GH, Kabani A, Louahlia S, Manning L, Maung R, Moore L, Philley J, Slatnik J, Srigley J, Thibault A, Picard DD, Cracower H, Tetu B.

J Pathol Inform. 2014 Mar 28;5(1):15. doi: 10.4103/2153-3539.129455. eCollection 2014.

24.

Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.

Moreel X, Allaire J, Léger C, Caron A, Labonté MÈ, Lamarche B, Julien P, Desmeules P, Têtu B, Fradet V.

Cancer Prev Res (Phila). 2014 Jul;7(7):766-76. doi: 10.1158/1940-6207.CAPR-13-0349. Epub 2014 May 13.

25.

Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis.

Trudel D, Desmeules P, Turcotte S, Plante M, Grégoire J, Renaud MC, Orain M, Bairati I, Têtu B.

Mod Pathol. 2014 Oct;27(10):1394-404. doi: 10.1038/modpathol.2014.32. Epub 2014 Mar 7.

26.

Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.

Lévesque É, Laverdière I, Lacombe L, Caron P, Rouleau M, Turcotte V, Têtu B, Fradet Y, Guillemette C.

Clin Cancer Res. 2014 Feb 1;20(3):576-84. doi: 10.1158/1078-0432.CCR-13-1100. Epub 2013 Nov 25.

27.

Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.

Brimo F, Aprikian A, Latour M, Têtu B, Doueik A, Scarlata E, Hamel L, McKercher G, Saad F, Lacombe L, Carmel M, Chevalier S.

Biopreserv Biobank. 2013 Oct;11(5):285-90.

28.

A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.

Trudel D, Labbé DP, Araya-Farias M, Doyen A, Bazinet L, Duchesne T, Plante M, Grégoire J, Renaud MC, Bachvarov D, Têtu B, Bairati I.

Gynecol Oncol. 2013 Nov;131(2):357-61. doi: 10.1016/j.ygyno.2013.08.019. Epub 2013 Aug 27.

PMID:
23988418
29.

Canadian licensure for the use of digital pathology for routine diagnoses: one more step toward a new era of pathology practice without borders.

Têtu B, Evans A.

Arch Pathol Lab Med. 2014 Mar;138(3):302-4. doi: 10.5858/arpa.2013-0289-ED. Epub 2013 Jun 26. No abstract available.

PMID:
23802851
30.

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.

Diaz Z, Aguilar-Mahecha A, Paquet ER, Basik M, Orain M, Camlioglu E, Constantin A, Benlimame N, Bachvarov D, Jannot G, Simard MJ, Chabot B, Gologan A, Klinck R, Gagnon-Kugler T, Lespérance B, Samson B, Kavan P, Alcindor T, Dalfen R, Lan C, Chabot C, Buchanan M, Przybytkowski E, Qureshi S, Rousseau C, Spatz A, Têtu B, Batist G.

Mod Pathol. 2013 Nov;26(11):1413-24. doi: 10.1038/modpathol.2013.81. Epub 2013 Jun 7.

31.

High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.

Ayari C, LaRue H, Hovington H, Caron A, Bergeron A, Têtu B, Fradet V, Fradet Y.

Hum Pathol. 2013 Aug;44(8):1630-7. doi: 10.1016/j.humpath.2013.01.014. Epub 2013 Apr 8.

PMID:
23574787
32.

Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease.

Florianova L, Orain M, Têtu B, Doillon CJ.

Biotech Histochem. 2013 Jul;88(5):222-34. doi: 10.3109/10520295.2012.758310. Epub 2013 Jan 21.

PMID:
23331188
33.

[The Eastern Quebec telepathology network: a real collective project].

Têtu B, Boulanger J, Houde C, Fortin JP, Gagnon MP, Roch G, Paré G, Trudel MC, Sicotte C.

Med Sci (Paris). 2012 Nov;28(11):993-9. doi: 10.1051/medsci/20122811021. Epub 2012 Nov 12. Review. French.

34.

Human epididymis protein 4 (HE4) and ovarian cancer prognosis.

Trudel D, Têtu B, Grégoire J, Plante M, Renaud MC, Bachvarov D, Douville P, Bairati I.

Gynecol Oncol. 2012 Dec;127(3):511-5. doi: 10.1016/j.ygyno.2012.09.003. Epub 2012 Sep 9.

PMID:
22967799
35.

The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.

Mauermann J, Fradet V, Lacombe L, Dujardin T, Tiguert R, Tetu B, Fradet Y.

Eur Urol. 2013 Jul;64(1):19-25. doi: 10.1016/j.eururo.2012.08.002. Epub 2012 Aug 10.

PMID:
22901983
36.

Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.

Trudel D, Labbé DP, Bairati I, Fradet V, Bazinet L, Têtu B.

Gynecol Oncol. 2012 Sep;126(3):491-8. doi: 10.1016/j.ygyno.2012.04.048. Epub 2012 May 4. Review.

PMID:
22564714
37.

The effects of a regional telepathology project: a study protocol.

Trudel MC, Paré G, Têtu B, Sicotte C.

BMC Health Serv Res. 2012 Mar 15;12:64. doi: 10.1186/1472-6963-12-64.

38.

The challenges of implementing a "patient-oriented" telepathology network; the Eastern Québec telepathology project experience.

Têtu B, Fortin JP, Gagnon MP, Louahlia S.

Anal Cell Pathol (Amst). 2012;35(1):11-8. doi: 10.3233/ACP-2011-0023.

39.

The First Congress of the International Academy of Digital Pathology: digital pathology comes of age.

Yagi Y, Rojo MG, Kayser K, Kayser G, Laurinavicius A, Della Mea V, Levy B, Klossa J, Tearney G, Szymas J, Tsuchihashi Y, Têtu B.

Anal Cell Pathol (Amst). 2012;35(1):1-2. doi: 10.3233/ACP-2011-0049. No abstract available.

40.

Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.

Brimo F, Sircar K, Chevalier S, Saad F, Lacombe L, Têtu B, Scarlata E, Aprikian A.

Cell Tissue Bank. 2012 Dec;13(4):631-8. doi: 10.1007/s10561-011-9284-y. Epub 2011 Dec 27.

PMID:
22200970
41.

Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.

Pâquet S, Fazli L, Grosse L, Verreault M, Têtu B, Rennie PS, Bélanger A, Barbier O.

J Clin Endocrinol Metab. 2012 Mar;97(3):E428-32. doi: 10.1210/jc.2011-2064. Epub 2011 Dec 14.

PMID:
22170718
42.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Têtu B, Bairati I, Bachvarov D.

Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.

43.

Value of sentinel node mapping in cancer of the cervix.

Roy M, Bouchard-Fortier G, Popa I, Grégoire J, Renaud MC, Têtu B, Plante M.

Gynecol Oncol. 2011 Aug;122(2):269-74. doi: 10.1016/j.ygyno.2011.04.002. Epub 2011 Apr 29.

PMID:
21529908
44.

Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Nourissat A, Bairati I, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Meyer F.

Support Care Cancer. 2012 Mar;20(3):591-9. doi: 10.1007/s00520-011-1132-x. Epub 2011 Mar 20.

PMID:
21424341
45.

Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans.

Bellemare J, Rouleau M, Harvey M, Popa I, Pelletier G, Têtu B, Guillemette C.

J Pathol. 2011 Feb;223(3):425-35. doi: 10.1002/path.2805. Epub 2010 Oct 29.

46.

Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics.

Audet-Walsh E, Lépine J, Grégoire J, Plante M, Caron P, Têtu B, Ayotte P, Brisson J, Villeneuve L, Bélanger A, Guillemette C.

J Clin Endocrinol Metab. 2011 Feb;96(2):E330-9. doi: 10.1210/jc.2010-2050. Epub 2010 Dec 8.

PMID:
21147881
47.

[Telepathology project on virtual slides of eastern Quebec: a clinical project carried out in 21 areas].

Têtu B, Boulanger J, Houde C.

Ann Pathol. 2010 Nov;30(5 Suppl 1):25-7. doi: 10.1016/j.annpat.2010.07.011. Epub 2010 Sep 28. French. No abstract available.

PMID:
21055536
48.

Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.

Trudel D, Fradet Y, Meyer F, Têtu B.

Hum Pathol. 2010 Dec;41(12):1694-701. doi: 10.1016/j.humpath.2010.05.001. Epub 2010 Sep 9.

PMID:
20825973
49.

Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.

Haince JF, Houde M, Beaudry G, L'espérance S, Garon G, Desaulniers M, Hafer LJ, Heald JI, Lyle S, Grossman SR, Têtu B, Sargent DJ, Fradet Y.

J Clin Pathol. 2010 Jun;63(6):530-7. doi: 10.1136/jcp.2009.072983.

PMID:
20498026
50.

Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.

Lépine J, Audet-Walsh E, Grégoire J, Têtu B, Plante M, Ménard V, Ayotte P, Brisson J, Caron P, Villeneuve L, Bélanger A, Guillemette C.

J Clin Endocrinol Metab. 2010 Jun;95(6):2689-98. doi: 10.1210/jc.2010-2648. Epub 2010 Apr 6.

PMID:
20371658

Supplemental Content

Support Center